Health Care: Drugs

Amicus Therapeutics Inc (FOLD: NASDAQ)

$4.26 0.16 | 3.9%
07/24/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 363.00K 18.41M 21.43M 922.00K
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 363.00K 18.41M 21.43M 922.00K
Selling, General, and Administrative Expenses 18.89M 19.36M 19.88M 15.66M
Research & Development 41.94M 50.27M 50.86M 39.04M
Operating Income before D & A (EBITDA) -60.47M -51.23M -49.30M -53.78M
Depreciation & Amortization 1.72M 1.70M 1.58M 2.06M
Interest Income 174.00K 316.00K 160.00K 156.00K
Other Income - Net 908.00K 674.00K 2.83M -133.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -63.10M -51.94M -47.89M -55.82M
Interest Expense 46.00K 89.00K 148.00K 260.00K
Pre-Tax Income -63.14M -52.03M -48.04M -56.08M
Income Taxes -3.51M -3.24M -3.63M -1.14M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -59.63M -48.78M -44.41M -54.94M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -59.63M -48.78M -44.41M -54.94M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -59.63M -48.78M -44.41M -54.94M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-57.64M -48.78M -44.41M -54.94M
Preferred Dividends
Net Income Available To Common -59.63M -48.78M -44.41M -54.94M
Basic EPS from Continuing Ops. -1.16 -1.07 -1.28 -1.98
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.16 -1.07 -1.28 -1.98
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.16 -1.07 -1.28 -1.98
Basic Normalized Net Income/Share -1.12 -1.07 -1.28 -1.98
EPS fr Continuing Ops. -1.16 -1.07 -1.28 -1.98
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.16 -1.07 -1.28 -1.98
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.16 -1.07 -1.28 -1.98
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.12 -1.07 -1.28 -1.98
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with FOLD

Latest FOLD Headlines from TheStreet

More Financial News for FOLD

Press Releases for FOLD

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter